Healthequity Inc
NASDAQ:HQY
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
76.77
114.51
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
HQY
stock under the Base Case scenario is
97.96
USD.
Compared to the current market price of 95.67 USD,
Healthequity Inc
is
Undervalued by 2%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Healthequity Inc.
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
|
| US |
A
|
Anthem Inc
LSE:0HG8
|
|
| US |
|
Elevance Health Inc
NYSE:ELV
|
|
| US |
|
Humana Inc
NYSE:HUM
|
|
| US |
|
Centene Corp
NYSE:CNC
|
|
| US |
|
Molina Healthcare Inc
NYSE:MOH
|
|
| US |
M
|
Magellan Health Inc
F:MAH1
|
|
| US |
|
Progyny Inc
NASDAQ:PGNY
|
|
| BR |
|
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
|
|
| US |
|
Clover Health Investments Corp
NASDAQ:CLOV
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
Healthequity Inc
Balance Sheet Decomposition
Healthequity Inc
| Current Assets | 492.8m |
| Cash & Short-Term Investments | 304.5m |
| Receivables | 111.2m |
| Other Current Assets | 77.2m |
| Non-Current Assets | 2.9B |
| PP&E | 42.8m |
| Intangibles | 2.8B |
| Other Non-Current Assets | 80.4m |
| Current Liabilities | 116.6m |
| Accounts Payable | 9.6m |
| Accrued Liabilities | 107m |
| Non-Current Liabilities | 1.2B |
| Long-Term Debt | 1B |
| Other Non-Current Liabilities | 146.8m |
Free Cash Flow Analysis
Healthequity Inc
| USD | |
| Free Cash Flow | USD |
Earnings Waterfall
Healthequity Inc
|
Revenue
|
1.3B
USD
|
|
Cost of Revenue
|
-426m
USD
|
|
Gross Profit
|
843m
USD
|
|
Operating Expenses
|
-569.4m
USD
|
|
Operating Income
|
273.6m
USD
|
|
Other Expenses
|
-127.8m
USD
|
|
Net Income
|
145.8m
USD
|
HQY Profitability Score
Profitability Due Diligence
Healthequity Inc's profitability score is 52/100. The higher the profitability score, the more profitable the company is.
Score
Healthequity Inc's profitability score is 52/100. The higher the profitability score, the more profitable the company is.
HQY Solvency Score
Solvency Due Diligence
Healthequity Inc's solvency score is 63/100. The higher the solvency score, the more solvent the company is.
Score
Healthequity Inc's solvency score is 63/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
HQY Price Targets Summary
Healthequity Inc
According to Wall Street analysts, the average 1-year price target for
HQY
is 122.33 USD
with a low forecast of 101 USD and a high forecast of 140.7 USD.
Dividends
Current shareholder yield for
HQY is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
HQY
stock under the Base Case scenario is
97.96
USD.
Compared to the current market price of 95.67 USD,
Healthequity Inc
is
Undervalued by 2%.